Ascendis Pharma A/S is a DK-based company operating in Biotechnology industry. Ascendis Pharma A/S is a Denmark‑based biopharmaceutical company operating within the life sciences and biotechnology sector. The firm scope of activity includes discovery, development, and commercialization of innovative therapies for rare diseases and serious chronic conditions with significant unmet medical needs where a clinically validated parent drug or pathway is suitable to company technologies. Ascendis Pharma A/S focuses on the endocrinology area and has a pipeline of three independent rare disease product candidates, such as Growth Hormone Deficiency (GHD), Hypoparathyroidism and Achondroplasia. The second therapeutic area is oncology, where the company focuses immunotherapy to targeted therapies.
Jan Mikkelsen is the President of Ascendis Pharma A/S, joining the firm since 2007.
What is the price performance of ASND stock?
The current price of ASND is $263.95, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Ascendis Pharma A/S?
Ascendis Pharma A/S belongs to Biotechnology industry and the sector is Health Care
What is Ascendis Pharma A/S market cap?
Ascendis Pharma A/S's current market cap is $15.9B
Is Ascendis Pharma A/S a buy, sell, or hold?
According to wall street analysts, 22 analysts have made analyst ratings for Ascendis Pharma A/S, including 11 strong buy, 11 buy, 1 hold, 0 sell, and 11 strong sell